Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
---|
03/08/2006 | CN1742834A Chinese medicine composition for treating diabets and preparing method |
03/08/2006 | CN1742781A Fat-reducing blood-fat-reducing Chinese medicine preparation |
03/08/2006 | CN1742772A Chinese medicinal preparation for treating sore, and wound and turn and scald |
03/08/2006 | CN1742759A Medicine for treating Youth acne varioliformis and preparing method |
03/08/2006 | CN1742758A Medicine for treating diaper rash and ezcema and preparing method |
03/08/2006 | CN1742741A Medicinal composition containing amino glucose and calcium agent and vitamin D and use thereof |
03/08/2006 | CN1244371C Chinese medicinal liquid for treating tinea on manus and pedes |
03/08/2006 | CN1244370C Medicinal composition for treating psoriasis |
03/08/2006 | CN1244369C Medicine for treating Sjogren syndrome and its preparing process |
03/08/2006 | CN1244367C Chinese medicine oral liquid for curing epilepsy sickness |
03/08/2006 | CN1244366C Tinea liquid medicine and its preparation method |
03/08/2006 | CN1244365C External use of Chinese herb medicinal mixture for treating mumps |
03/08/2006 | CN1244363C Liver cirrhosis and arteriosclerosis pharmaceutical composition |
03/08/2006 | CN1244361C Medicinal composition for curing oral and throat diseases and its preparing method and use |
03/08/2006 | CN1244353C Medicine for curing acne and its preparation method |
03/08/2006 | CN1244345C Chinese medicine composition for treating thromboangiitis obliterans and its preparing method |
03/07/2006 | US7008913 Aromatic substituted nonionic surfactants in soil prevention, reduction or removal in treatment zones |
03/07/2006 | US7008647 Treatment of acne |
03/07/2006 | US7008645 Bisphosphonate compound |
03/02/2006 | WO2006023714A2 Dithiocarbamate derivatives and their use for treating cancer |
03/02/2006 | WO2005123193A3 Treatments comprising strontium for rheumatic and arthritic diseases and pain |
03/02/2006 | WO2005084462A3 Nanoscale and supersaturated solutions of mineral or trace elements and a method for production of nanoparticles mixtures of nanoparticles, nanoscale solutions and general supersaturated solutions |
03/02/2006 | WO2005067945A3 Use of a xenon/carbon monoxide mixture for the protection of cells |
03/02/2006 | US20060045919 Homeopathic compositions and methods for the treatment of cancer |
03/02/2006 | US20060045916 Methods for producing silver nanoparticles |
03/02/2006 | US20060045883 Anti-cancer vaccines |
03/02/2006 | DE102005035472A1 Chemische Dialysatformulierungen auf Citratbasis Dry on citrate dialysate |
03/01/2006 | EP1630136A1 Surface-modified titanium dioxide fine particles and dispersion comprising the same, and method for producing the same |
03/01/2006 | EP1629856A2 Solution for peritoneal dialysis and two-chambers bag containing it |
03/01/2006 | EP1629838A1 Footcare product with glycerin and no added water |
03/01/2006 | EP1628986A2 Synthesis of high molecular weight iron-saccharidic complexes |
03/01/2006 | EP1628912A2 Use of pulverulent mixtures containing hydrogen peroxide and hydrophobed silicon dioxide for the controlled release of hydrogen peroxide or oxygen |
03/01/2006 | EP1628687A2 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
03/01/2006 | EP1628683A2 Vaccine composition comprising iron phosphate as a pharmaceutical aid to said vaccine |
03/01/2006 | EP1628672A2 Composition and use of pure iodine dissolved in essential oil of melaleuca alternifolia and/or melaleuca quinquenervia |
03/01/2006 | EP1628671A1 Rock flour, especially dolomite-based medicament, for the treatment of cancer diseases |
03/01/2006 | EP1628658A1 Nutritional composition and method of inhibiting smooth muscle cell contraction thereof |
03/01/2006 | EP1628657A2 Method for treating diseases using hsp90-inhibiting agents in combination with platinum coordination complexes |
03/01/2006 | EP1296667B1 Compounds for preventing and/or treating urticaria |
03/01/2006 | EP1244433B1 Use of non-human SHIP2 knock-out mammals |
03/01/2006 | CN1739773A Cholelithiasis treating medicine and its prepn |
03/01/2006 | CN1739754A Lotion for treating mycotic vaginitis |
03/01/2006 | CN1739739A Chinese medicine prepn for treating ulcer and its prepn process and quality control method |
03/01/2006 | CN1739706A Tongue dropping medicine pill for diminishing inflammation and detoxicating |
03/01/2006 | CN1739703A Fracture treating Chinese medicine |
03/01/2006 | CN1739661A Human body knee joint lubricating balance regulating ointment |
03/01/2006 | CN1739592A Externally applied medicine for treating toothache |
03/01/2006 | CN1739589A Fracture setting medicine |
03/01/2006 | CN1739587A Burn and scald ointment and its prepn |
03/01/2006 | CN1739575A Solid and liquid attapulgite prepn for treating digestive tract diseases |
03/01/2006 | CN1739574A Dietotherapeutic nutrient for preventing and treating gout and its prepn process |
03/01/2006 | CN1739573A Dietotherapeutic nutrient for preventing and treating primary gout and its prepn process |
03/01/2006 | CN1739572A Dietotherapeutic nutrient for preventing and treating primary and secondary gout and its prepn process |
03/01/2006 | CN1739571A Dietotherapeutic nutrient for preventing and treating non-insulin dependent diabetes and its prepn process |
03/01/2006 | CN1739570A Dietotherapeutic nutrient for preventing and treating hyperglycemia and diabetes and its prepn process |
03/01/2006 | CN1739569A Dietotherapeutic nutrient for preventing and treating non-insulin independent diabetes and its prepn process |
03/01/2006 | CN1739568A Dietotherapeutic nutrient for preventing and treating adipose diabetes and its prepn process |
03/01/2006 | CN1739567A Dietotherapeutic nutrient for preventing and treating adipose hyperglycemia and slimming and its prepn process |
03/01/2006 | CN1739566A Dietotherapeutic nutrient for preventing and treating hyperglycemia and its prepn process |
03/01/2006 | CN1739565A Dietotheraupeutic nutrient for preventing and treating secondary diabetes and its prepn process |
03/01/2006 | CN1739564A Dietotherapeutic nutrient for preventing and treating diabetes and its prepn process |
03/01/2006 | CN1739563A Medicated cream and its prepn process |
03/01/2006 | CN1739562A Application of metal fullerol in inhibiting tumor growth |
03/01/2006 | CN1739561A Application of high permeability medicine composition in preparing pre-nacrosis medicine |
03/01/2006 | CN1739560A Dietotherapeutic product for preventing and treating urate calculi, gout and acalcerosis and its prepn process |
03/01/2006 | CN1739559A Dietotherapeutic product for preventing and treating secondary urate calculi, gout and acalcerosis and its prepn process |
03/01/2006 | CN1739558A Dietotherapeutic product for preventing and treating primary and secondary urate calculi, gout and acalcerosis and its prepn process |
03/01/2006 | CN1739557A Dietotherapeutic product for preventing and treating primary urate calculi, gout and acalcerosis and its prepn process |
03/01/2006 | CN1739556A Dietotherapeutic nutrient for preventing and treating secondary gout and its prepn process |
03/01/2006 | CN1739555A Dietotherapeutic nutrient for preventing and treating non-insulin dependent hyperglycemia and obesity and its prepn process |
03/01/2006 | CN1739554A Dietotherapeutic nutrient for preventing and treating secondary urate calculi and gout and its prepn process |
03/01/2006 | CN1739553A Dietotherapeutic nutrient for preventing and treating urate calculi and gout and its prepn process |
03/01/2006 | CN1739552A Dietotherapeutic nutrient for treating primary and secondary urate calculi acid gout and its prepn process |
03/01/2006 | CN1739551A Dietotherapeutic nutrient for treating primary urate calculi and gout and its prepn process |
03/01/2006 | CN1739531A Ferric saccharate injection for treating iron-deficiency anemia and its prepn process |
03/01/2006 | CN1243562C Yang-strengthening chlorophyta tortoise capsule and its preparation |
03/01/2006 | CN1243558C Externally applied medicine for treating bone ulcer and its preparation method |
02/28/2006 | US7005133 Composition and process for treating pollution |
02/28/2006 | US7005124 High drug efficiency, high drug carrying capacity, good water solubility, good stability on storage, reduced toxicity, and improved anti-tumor activity in vivo |
02/23/2006 | WO2006020739A2 Compositions and methods for nutrition supplementation |
02/23/2006 | WO2006020727A2 Methods for treating cns disorders by administration of agents to the nasal cavity |
02/23/2006 | WO2006018655A1 Use of xenon as neuroprotectant in a neonatal subject |
02/23/2006 | US20060040903 Methods of use related to xerostomia |
02/23/2006 | US20060040898 Novel boronate esters |
02/23/2006 | US20060040002 Anti-itch composition |
02/23/2006 | US20060039997 Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration |
02/23/2006 | US20060039996 Method for treating sepsis |
02/23/2006 | US20060039995 Methods for providing neuroprotection for the animal central nervous system against the effects of ischemia, neurodegeneration, trauma, and metal poisoning |
02/23/2006 | US20060039994 Aluminophosphate-based materials for the treatment of wounds |
02/23/2006 | US20060039954 Comprising two or more additional ocular-active nutrients selected from lipoic acid, omega-3 fatty acids, plant-derived compounds such as flavonoids, anthocyanins, or polyphenolics, taurine, carnitine, Coenzyme-Q10, carnosine, and nutrients that stimulate production of glutathione; macular degeneration |
02/23/2006 | US20060039951 Inorganic shaped bodies and methods for their production and use |
02/23/2006 | US20060037910 Comprise liquid or dry acid concentrate unit stored in first vessel, and liquid or dry citrate-containing bicarbonate concentrate unit stored in second vessel; contents of first and second vessels are emptied into dialysate preparation tank and mixed with water to form batch of dialysate |
02/23/2006 | CA2781626A1 Use of xenon as neuroprotectant in a neonatal subject |
02/23/2006 | CA2577620A1 Method of detecting and treating allogenic cells responsible for endometriosis |
02/23/2006 | CA2577135A1 Deuterium depleted water (ddw) using as adjuvant in cancer therapy for cytostatics toxicity reduction |
02/23/2006 | CA2576156A1 Use of xenon as neuroprotectant in a neonatal subject |
02/23/2006 | CA2576049A1 Methods for providing neuroprotection for the animal central nervous system against the effects of ischemia, neurodegeneration, trauma, and metal poisoning |
02/22/2006 | EP1627663A2 Use of a pharmaceutical composition for the treatment of pathologies derived from infection by herpes virus, papillomavirus, hepatitis virus, viral neuralgia, viral dsyplasia, immune-deficiency-induced viral infections and viral neuritis. |
02/22/2006 | EP1627645A1 Antitumor agent and process for producing the same |
02/22/2006 | EP1627641A1 Pharmaceutical compositions comprising metal oxides and uses thereof |